Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+8.73%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$40.6B
AUM Growth
+$1.8B
(+4.6%)
Cap. Flow
-$667M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
14.98%
Holding
3,307
New
654
Increased
625
Reduced
659
Closed
844
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$477M |
| 2 |
Walmart
WMT
|
+$432M |
| 3 |
Microsoft
MSFT
|
+$331M |
| 4 |
Amazon
AMZN
|
+$329M |
| 5 |
GE Aerospace
GE
|
+$300M |
Top Sells
| 1 |
lululemon athletica
LULU
|
+$276M |
| 2 |
Cigna
CI
|
+$274M |
| 3 |
Exxon Mobil
XOM
|
+$272M |
| 4 |
Bank of America
BAC
|
+$253M |
| 5 |
Qualcomm
QCOM
|
+$234M |
Sector Composition
| 1 | Healthcare | 19.67% |
| 2 | Technology | 16.71% |
| 3 | Consumer Discretionary | 16.19% |
| 4 | Financials | 11.48% |
| 5 | Industrials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Biomea Fusion
BMEA
$115M
| $334K | ﹤0.01% |
10,776
-12,162
| -53% | -$377K |
|
1752
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.34B
| $334K | ﹤0.01% |
+7,400
| New | +$334K |
|
1753
Avantis US Equity ETF
AVUS
$9.6B
| $333K | ﹤0.01% |
+4,700
| New | +$333K |
|
1754
Glaukos
GKOS
$4.75B
| $333K | ﹤0.01% |
+6,637
| New | +$333K |
|
1755
Reinsurance Group of America
RGA
$12.7B
| $332K | ﹤0.01% |
+2,500
| New | +$332K |
|
1756
Moderna
MRNA
$9.15B
| $332K | ﹤0.01% |
2,161
-287,481
| -99% | -$44.2M |
|
1757
John Wiley & Sons Class A
WLY
$2.19B
| $331K | ﹤0.01% |
+8,542
| New | +$331K |
|
|
AMRN
1758
Amarin Corp
AMRN
$310M
| $331K | ﹤0.01% |
+11,031
| New | +$331K |
|
1759
iShares US Oil Equipment & Services ETF
IEZ
$113M
| $330K | ﹤0.01% |
+17,060
| New | +$330K |
|
1760
TransAlta
TAC
$3.75B
| $329K | ﹤0.01% |
+37,605
| New | +$329K |
|
1761
Arthur J. Gallagher & Co
AJG
$76.2B
| $328K | ﹤0.01% |
+1,715
| New | +$328K |
|
1762
Cross Country Healthcare
CCRN
$411M
| $324K | ﹤0.01% |
+14,500
| New | +$324K |
|
1763
iShares MSCI Australia ETF
EWA
$1.55B
| $323K | ﹤0.01% |
+14,100
| New | +$323K |
|
1764
Wabtec
WAB
$32.3B
| $323K | ﹤0.01% |
+3,200
| New | +$323K |
|
1765
LendingTree
TREE
$978M
| $323K | ﹤0.01% |
12,100
-5,200
| -30% | -$139K |
|
1766
Texas Pacific Land
TPL
$21.5B
| $320K | ﹤0.01% |
564
-9
| -2% | -$5.1K |
|
1767
Infosys
INFY
$70.3B
| $320K | ﹤0.01% |
+18,325
| New | +$320K |
|
|
TGI
1768
DELISTED
Triumph Group
TGI
| $317K | ﹤0.01% |
+27,352
| New | +$317K |
|
1769
Invesco Food & Beverage ETF
PBJ
$93.6M
| $317K | ﹤0.01% |
6,835
-8,547
| -56% | -$396K |
|
1770
Janus International
JBI
$1.44B
| $317K | ﹤0.01% |
+32,116
| New | +$317K |
|
1771
Global X MSCI China Consumer Discretionary ETF
CHIQ
$245M
| $316K | ﹤0.01% |
+15,674
| New | +$316K |
|
1772
Accuray
ARAY
$177M
| $316K | ﹤0.01% |
106,408
+28,847
| +37% | +$85.7K |
|
|
NVCN
1773
DELISTED
Neovasc Inc.
NVCN
| $316K | ﹤0.01% |
+10,834
| New | +$316K |
|
1774
Protalix BioTherapeutics
PLX
$144M
| $316K | ﹤0.01% |
+150,358
| New | +$316K |
|
1775
Werewolf Therapeutics
HOWL
$65.4M
| $314K | ﹤0.01% |
+120,936
| New | +$314K |
|